Amulet Capital Partners has successfully closed its third niche life sciences fund, raising significant capital to invest in subsectors such as healthcare services, medical devices, and pharmaceuticals. The fund aims to capitalize on emerging opportunities in these areas by targeting middle-market companies that offer growth potential and value creation. This latest fund highlights Amulet Capital’s commitment to expanding its presence in the life sciences sector.
Keep Reading
Add A Comment